PharmaCyte Biotech Inc (PMCB)

[DragonBear]

What I don’t understand is why they and

other eminent doctors would join pharmacyte if they believed it was a scam and the technology doesn’t work.

As you later suggest... money.

Actually austrianova has received millions from pharmacyte and is now getting another 900,000 in the next six months so that’s a good reason I guess.

Yes the latest PR where they had to address Canadian regulator concerns, outlines how Austrianova received $2M for each intended use of CIAB. Gunzberg is a founder of Austrianova. Why wouldn't he want to associate with PMCB, and influence new amendments, funneling more money into Austrianova?

I am sure Dr Lohr believes in the therapy

Lohr believes agreeing to become a consultant for staging trials will put some money into his pocket. One of the earliest mention of him in that role for PMCB was to stage Phase 2 trials in Australia. If one does a search of the Australian clinical trial database for pancreatic cancer, there has never been a trial staged involving CIAB, or Ifosfamide. This isn't some holy grail crusade by Lohr in "believes". Doesn't matter to Lohr, if imaginary Australian clinical trials never took place. Lohr is getting paid to act as a consultant.

It feels like it doesn’t add up because with everyone chasing encapsulation for diabetes how could this therapy not attract attention or funding?

Go to the JDRF site. Read the article on the startup funding. They have their own proprietary encapsulation, claiming superior immune protection. And they use stem cell derived Islets. Note it has backing from the likes of Novartis. Why doesn't it add up, that advances have been made in encapsulation in the last 20 yrs? Or that the emphasis has shifted to stem cells rather than a tissue culture cell line (Magellan)? Next step will be someone finding a way to coax an individual's stem cells into Islets, and avoid the immunity problem.

Kenny has been pumping CIAB+Metronomic Ifosfamide chemo for Pancreatic cancer. No other drug company in the world is interested in Metronomic chemo with an alkylating agent against Pancreatic cancer. The world has moved onto targeted antibody therapy, along with new drugs. In addition Kenny has told the SHs, the FDA is wanting pre-clinical data. As in animal testing of a stable cell line. Possibly years away from an IND.

Kenny has been pumping CIAB for diabetes. But as discussed above, once again it's antiquated. And nothing has happened since 2014.

Kenny's final fallback scam angle try is cannabinoids being used against cancer. Where he would replay the CIAB+Ifosfamide, swapping out the Ifosfamide for some cannibinoid derivative. That one will also go nowhere.

As long as PMCB can sell its stock to retail investors, Kenny gets his salary, and Gunzberg, Lohr, along with others gets their consulting fees. In the case of Gunzberg arranging $2M here and there to flow into Austrianova from PMCB is even better. That's the game.